These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1061 related articles for article (PubMed ID: 31221822)
1. Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease. Guo J; Liu Z; Gong R Clin Sci (Lond); 2019 Jun; 133(12):1321-1339. PubMed ID: 31221822 [TBL] [Abstract][Full Text] [Related]
2. Dysregulated expression but redundant function of the long non-coding RNA HOTAIR in diabetic kidney disease. Majumder S; Hadden MJ; Thieme K; Batchu SN; Niveditha D; Chowdhury S; Yerra VG; Advani SL; Bowskill BB; Liu Y; Vakili H; Alghamdi TA; White KE; Geldenhuys L; Siddiqi FS; Advani A Diabetologia; 2019 Nov; 62(11):2129-2142. PubMed ID: 31399844 [TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA ENSG00000254693 Promotes Diabetic Kidney Disease via Interacting with HuR. Yu Q; Lin J; Ma Q; Li Y; Wang Q; Chen H; Liu Y; Liu B J Diabetes Res; 2022; 2022():8679548. PubMed ID: 35493610 [TBL] [Abstract][Full Text] [Related]
5. Early growth response protein-1 upregulates long noncoding RNA Arid2-IR to promote extracellular matrix production in diabetic kidney disease. Yang YL; Hu F; Xue M; Jia YJ; Zheng ZJ; Li Y; Xue YM Am J Physiol Cell Physiol; 2019 Mar; 316(3):C340-C352. PubMed ID: 30462533 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNAs may impact podocytes and proximal tubule function through modulating miRNAs expression in Early Diabetic Kidney Disease of Type 2 Diabetes Mellitus patients. Petrica L; Hogea E; Gadalean F; Vlad A; Vlad M; Dumitrascu V; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Jianu DC; Matusz P; Pusztai AM; Motoc A; Cretu OM; Radu D; Milas O; Golea-Secara A; Simulescu A; Mogos-Stefan M; Patruica M; Balint L; Ienciu S; Vlad D; Popescu R Int J Med Sci; 2021; 18(10):2093-2101. PubMed ID: 33859515 [No Abstract] [Full Text] [Related]
7. Co-expression analysis among microRNAs, long non-coding RNAs, and messenger RNAs to understand the pathogenesis and progression of diabetic kidney disease at the genetic level. Zhang L; Li R; He J; Yang Q; Wu Y; Huang J; Wu B Methods; 2017 Jul; 124():46-56. PubMed ID: 28577935 [TBL] [Abstract][Full Text] [Related]
8. IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes. Lay AC; Hale LJ; Stowell-Connolly H; Pope RJP; Nair V; Ju W; Marquez E; Rollason R; Hurcombe JA; Hayes B; Roberts T; Gillam L; Allington J; Nelson RG; Kretzler M; Holly JMP; Perks CM; McArdle CA; Welsh GI; Coward RJM Diabetologia; 2021 Jul; 64(7):1690-1702. PubMed ID: 33758952 [TBL] [Abstract][Full Text] [Related]
9. The role of long non-coding RNAs in the development of diabetic kidney disease and the involved clinical application. Hou Q; Yi B Diabetes Metab Res Rev; 2024 May; 40(4):e3809. PubMed ID: 38708843 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA NEAT1 is involved in the protective effect of Klotho on renal tubular epithelial cells in diabetic kidney disease through the ERK1/2 signaling pathway. Yang YL; Xue M; Jia YJ; Hu F; Zheng ZJ; Wang L; Si ZK; Xue YM Exp Mol Med; 2020 Feb; 52(2):266-280. PubMed ID: 32054986 [TBL] [Abstract][Full Text] [Related]
11. LncRNA H19: a novel player in the regulation of diabetic kidney disease. Wu Q; Huang F Front Endocrinol (Lausanne); 2023; 14():1238981. PubMed ID: 37964955 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNAs-towards precision medicine in diabetic kidney disease? Panchapakesan U; Pollock C Clin Sci (Lond); 2016 Sep; 130(18):1599-602. PubMed ID: 27503944 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNAs in the pathogenesis of diabetic kidney disease: implications for novel therapeutic strategies. Leti F; Morrison E; DiStefano JK Per Med; 2017 May; 14(3):271-278. PubMed ID: 29767584 [TBL] [Abstract][Full Text] [Related]
14. The Impact of lncRNA on Diabetic Kidney Disease: Systematic Review and In Silico Analyses. Zhao Y; Yan G; Mi J; Wang G; Yu M; Jin D; Tong X; Wang X Comput Intell Neurosci; 2022; 2022():8400106. PubMed ID: 35528328 [TBL] [Abstract][Full Text] [Related]
15. Polysaccharides from Dendrobium officinale delay diabetic kidney disease interstitial fibrosis through LncRNA XIST/TGF-β1. Zhang Y; Deng Y; Yang Y; Yang Z; Yin Y; Xie J; Ding J; Shang Y; Zha Y; Yuan J Biomed Pharmacother; 2024 Jun; 175():116636. PubMed ID: 38677245 [TBL] [Abstract][Full Text] [Related]
16. Interactions among Long Non-Coding RNAs and microRNAs Influence Disease Phenotype in Diabetes and Diabetic Kidney Disease. Srivastava SP; Goodwin JE; Tripathi P; Kanasaki K; Koya D Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199672 [TBL] [Abstract][Full Text] [Related]
17. A novel long non-coding RNA CYP4B1-PS1-001 regulates proliferation and fibrosis in diabetic nephropathy. Wang M; Wang S; Yao D; Yan Q; Lu W Mol Cell Endocrinol; 2016 May; 426():136-45. PubMed ID: 26923441 [TBL] [Abstract][Full Text] [Related]
18. EA15, MIR22, LINC00472 as diagnostic markers for diabetic kidney disease. Wang YZ; Zhu DY; Xie XM; Ding M; Wang YL; Sun LL; Zhang N; Shen E; Wang XX J Cell Physiol; 2019 Jun; 234(6):8797-8803. PubMed ID: 30317603 [TBL] [Abstract][Full Text] [Related]
19. Glomerular endothelial cell injury and cross talk in diabetic kidney disease. Fu J; Lee K; Chuang PY; Liu Z; He JC Am J Physiol Renal Physiol; 2015 Feb; 308(4):F287-97. PubMed ID: 25411387 [TBL] [Abstract][Full Text] [Related]
20. Microarray analysis of long noncoding RNA expression patterns in diabetic nephropathy. Chen S; Dong C; Qian X; Huang S; Feng Y; Ye X; Miao H; You Q; Lu Y; Ding D J Diabetes Complications; 2017 Mar; 31(3):569-576. PubMed ID: 28007334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]